Global In-Silico Drug Discovery Industry Forecasts to 2029 – Integration of Blockchain Technology in Interoperability Presents Massive Opportunities -…

DUBLIN, Feb. 14, 2020 /PRNewswire/ -- The "Global In-Silico Drug Discovery Market: Focus on Products, Technologies, Workflow, End Users, Country Data (17 Countries), and Competitive Landscape - Analysis and Forecast, 2018-2029" report has been added to ResearchAndMarkets.com's offering.

The in-silico drug discovery industry analysis projects the market to grow at a significant CAGR of 12.92% during the forecast period, 2019-2029. The in-silico drug discovery market generated $2,094.5 million in revenue in 2018, in terms of value.

The global in-silico drug discovery market growth has been primarily attributed to the major drivers in this market such as an emphasis on the reduction in medical errors and readmission rates, growth in the biomarker identification market and advancements in In-silico drug discovery techniques, and computational technological advancements in the field of computational biology.

However, there are significant challenges that are restraining the market growth. These challenges include the high cost of methods and expensive procedures and their applications in medical treatments.

Expert Quote

North America is the leading contributor to the in-silico drug discovery market and contributed approximately 41.65% to the global market value in 2018. This region is anticipated to grow at a significant CAGR during the forecast period 2019-2029 and continue dominating the global market in 2029. However, the Asia-Pacific region is expected to grow at the highest CAGR of 13.29% during the forecast period. In addition, the region of Europe also contributed a significant share of 28.40% to the global market in 2018.

Scope of the Market Intelligence

The in-silico drug discovery research provides a holistic view of the market in terms of various factors influencing it, including regulatory reforms, and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the service market. In addition, the study also includes exhaustive information on the unmet needs, perception of the new products, competitive landscape, market share of leading manufacturers, the growth potential of each underlying sub-segment, and company, as well as other vital information with respect to the global in-silico drug discovery market.

Key Companies in the Market

The key manufacturers who have been contributing significantly to the global in-silico drug discovery market include Albany Molecular Research Inc., Certara USA, Inc., Charles River, Chemical Computing Group ULC, Collaborative Drug Discovery Inc., Dassault System (Biovia), Evotec A.G., GVK Biosciences Private Limited, ICAGEN, INC., Novo Informatics Pvt. Ltd., Numerate Inc., PerkinElmer Inc, Schrdinger, LLC, Selvita, Simulation Plus, and WuXi AppTec, among others.

Key Questions Answered in the Report

Key Topics Covered

1 Product Definition1.1 Inclusion and Exclusion

2 Research Scope2.1 Scope of the Study2.2 Key Questions Answered in the Report

3 Research Methodology3.1 Global In-Silico Drug Discovery Market: Research Methodology3.2 Primary Data Sources3.3 Secondary Data Sources3.4 Market Estimation Model

4 Industry Analysis4.1 Regulatory Framework4.1.1 Regulatory Framework in North America4.1.2 Regulatory Framework in Europe4.1.3 Regulatory Framework in Asia-Pacific

5 Competitive Landscape5.1 Mergers and Acquisitions5.2 Product Launches and Product Updates5.3 Synergistic Activities5.4 Business Expansion Activities and Others5.5 Market Share Analysis

6 Market Dynamics6.1 Overview6.2 Impact Analysis6.3 Market Drivers6.3.1 Emphasis on Reduction in Medical Errors and Readmission Rates6.3.2 Growth in the Biomarker Identification Market and Advancements in In-Silico Drug Discovery Techniques6.3.3 Technological Advancements in the Field of Computational Biology6.4 Market Restraints6.4.1 Lack of High Complexity Testing Centers6.4.2 Expensive Procedures and Their Applications in Medical Treatments6.4.3 High Capital Requirement Hampering the Expansion of Global Reach6.5 Market Opportunities6.5.1 Massive Scope for Adoption of In-Silico Drug Discovery in Developing Nations6.5.2 Integration of Blockchain Technology in Interoperability6.5.3 Collaborations With Precision Medicine Providers

7 In-Silico Drug Discovery: Overview7.1 Introduction7.2 Market Availability for In-Silico Drug Discovery7.3 In-Silico Drug Discovery Market Technology Trends

8 Global In-Silico Drug Discovery Market (by Workflow)8.1 Overview8.2 Discovery8.2.1 Target Identification8.2.1.1 Bioinformatics8.2.1.2 Reverse Docking8.2.1.3 Protein Structure Prediction8.2.2 Target Validation8.2.3 Lead Discovery8.2.3.1 Library Design8.2.3.2 Pharmacophore8.3 Pre-Clinical Tests8.4 Clinical Trials

9 Global In-Silico Drug Discovery Market (by Product)9.1 Software9.2 Software as-a-Service (Cloud)9.3 Consultancy as-a-Service

10 Global In-Silico Drug Discovery Market (by Software Type)10.1 Molecular Modeling and de Novo Drug Design Software10.2 Pharmacophore Modeling Software

11 Global In-Silico Drug Discovery Market (by End-user)11.1 Contract Research Organizations11.2 Pharmaceutical Industry11.3 Academic and Research Institutes11.4 Other End-users (Hospitals and Other Care Facilities)

12 Global In-Silico Drug Discovery Market, by Region12.1 Overview12.2 North America12.2.1 U.S.12.2.2 Canada12.3 Europe12.3.1 Germany12.3.2 France12.3.3 U.K.12.3.4 Italy12.3.5 Spain12.3.6 Russia12.3.7 Rest-of-Europe12.4 Asia-Pacific12.4.1 China12.4.2 Japan12.4.3 Australia12.4.4 India12.4.5 South Korea12.4.6 Rest-of-APAC12.5 Latin America12.5.1 Brazil12.5.2 Mexico12.6 Rest-of-the-World

13 Company Profiles13.1 Overview13.2 Albany Molecular Research Inc.13.2.1 Company Overview13.2.2 Role of Albany Molecular Research in the Global In-Silico Drug Discovery Market13.2.3 SWOT Analysis13.3 Certara USA Inc.13.4 Charles River13.5 Chemical Computing Group ULC13.6 Collaborative Drug Discovery Inc.13.7 Dassault System (Biovia)13.8 Evotec AG13.9 GVK Biosciences Private Limited13.10 ICAGEN Inc.13.11 Novo Informatics Pvt. Ltd.13.12 Numerate Inc.13.13 PerkinElmer Inc.13.14 Schrdinger LLC13.15 Selvita13.16 Simulation Plus13.17 WuXi AppTec13.18 e-therapeutics plc (Snapshot)

For more information about this report visit https://www.researchandmarkets.com/r/2rpum3

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-in-silico-drug-discovery-industry-forecasts-to-2029---integration-of-blockchain-technology-in-interoperability-presents-massive-opportunities-301005260.html

SOURCE Research and Markets

See original here:
Global In-Silico Drug Discovery Industry Forecasts to 2029 - Integration of Blockchain Technology in Interoperability Presents Massive Opportunities -...